Belimumab Recruiting Phase 4 Trials for Sjögren's Syndrome (SS) / Acute Lymphocytic Leukemia, Pediatric Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT06410833Belimumab After Rituximab in Resistant Primary Juvenile SS